Identification of APEX2 as an oncogene in liver cancer

doi:10.12998/wjcc.v8.i14.2917

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9518)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

526

WORD

206

HTML

4495

Figures (1-7)

527

Sum=5754

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

410

Download

899

Sum=1309

Publishing Process of This Article

Item

Count

Browse

676

Download

1779

Sum=2455

Jul 26, 2020 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Jul 26, 2020; 8(14): 2917-2929
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2917

Full Size Figure Download Figure

Figure 4 The GSEA analysis based on APEX2 expression. A: The TCGA liver hepatocellular carcinoma (LIHC) samples were subjected to GSEA analysis, and 195 cases of LIHC samples were set as APEX2 high group, 205 cases of LIHC samples were set as APEX2 low group; B: The cellular component analysis based on GSEA was conducted, and the two main cellular components were shown; C: The APEX2-associated biological process was achieved by GSEA analysis. NES: Normalized Enrichment Score; TCGA: The Cancer Genome Atlas; GSEA: Gene Set Enrichment Analysis.

Citation: Zheng R, Zhu HL, Hu BR, Ruan XJ, Cai HJ. Identification of APEX2 as an oncogene in liver cancer. World J Clin Cases 2020; 8(14): 2917-2929
URL: https://www.wjgnet.com/2307-8960/full/v8/i14/2917.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i14.2917